已收盘 03-26 16:00:00 美东时间
0.000
0.00%
Sanofi ( ($SNY) ) has shared an announcement. On October 22, 2025, Sanofi annou...
今天 02:18
<p>Dupixent, developed by Regeneron, has been awarded the 2025 "Best Biotechnology Product" by the Galien Foundation. It is the first and only therapy targeting the IL-4 and IL-13 signaling pathway, key drivers of type 2 inflammation. Dupixent is approved for eight conditions, including atopic dermatitis, asthma, and COPD, and has helped over 1 million patients globally. The therapy's innovative approach redefines understanding of allergic and at...
10-31 11:00
Nurix Therapeutics' CEO Arthur T. Sands will participate in fireside chats at Stifel 2025 Healthcare Conference in New York on November 13, and Jefferies Global Healthcare Conference in London on November 19. These sessions will be webcast live and archived for 30 days on the company's Investors page. Nurix focuses on developing targeted protein degradation medicines for cancer and inflammatory diseases, with a pipeline including degraders of BTK...
10-30 11:00
Sanofi (NASDAQ:SNY) is extending an ongoing relationship with Medidata, with provides software as a service offerings for life sciences companies to assist with clinical trials. The French pharma will...
10-29 00:55
An announcement from Sanofi ( ($SNY) ) is now available. On October 28, 2025, S...
10-28 23:13
专题:聚焦2025年第三季度美股财报 再生元制药公司(Regeneron Pharmaceuticals)于周二公布的第三季度业绩超出华尔...
10-28 21:20
瑞士制药巨头诺华(Novartis)于周日宣布,已同意以约 120 亿美元现金收购美国生物技术公司 Avidity Biosciences。此次收购旨在扩充...
10-27 18:08
SuperX AI (NASDAQ: SUPX) invests in MicroInference Pte. Ltd., strengthening its supply chain for NVIDIA servers and networking equipment.
10-25 00:58
Sanofi Q3 sales beat estimates on strong Dupixent and new drug demand; reaffirms 2025 outlook with double-digit EPS growth expected.
10-24 22:47
Sanofi shares are trading higher after the company reported Q3 EPS and sales ab...
10-24 21:25